<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03475017</url>
  </required_header>
  <id_info>
    <org_study_id>Denisemafra4</org_study_id>
    <nct_id>NCT03475017</nct_id>
  </id_info>
  <brief_title>Effects of Curcumin in Patients in Chronic Kidney Disease</brief_title>
  <official_title>Effects of Curcumin Supplementation in Inflammation, Oxidative Stress and Intestinal Microbiota in Patients With Chronic Kidney Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Denise Mafra</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidade Federal Fluminense</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Many studies have been conducted to identify therapeutic strategies to modulate inflammation
      and oxidative stress, complications that contribute to the increased morbidity and
      cardiovascular mortality in patients with chronic kidney disease (CKD). Among several
      non-pharmacological strategies, the use of bioactive compounds has emerged as a potential
      approach to reduce these complications in CKD patients. In this context, turmeric/curcumin
      may have positive consequences in terms of cardiovascular and nephroprotection because of its
      antibacterial, antiviral, anti-inflammatory and anti-oxidative effects. The aim of this study
      is the role of curcumin as a nutritional strategy to reduce cardiovascular risk factors as
      inflammation and oxidative stress in CKD patients.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">February 22, 2018</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Antioxidants and anti-inflammatory biomarkers</measure>
    <time_frame>4 weeks</time_frame>
    <description>Get blood samples to evaluate the supplementation effects in antioxidants biomarkers- nuclear receptor factor 2 (Nrf2), glutathioneperoxidase (GPx), heme oxygenase-1 (HO-1)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Inflammatory biomarkers</measure>
    <time_frame>4 weeks</time_frame>
    <description>Get blood samples to evaluate the supplementation effects in inflammatory biomarkers- factor nuclear kappa B (NFkB), interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-alpha)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Chronic Kidney Diseases</condition>
  <arm_group>
    <arm_group_label>Supplement A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Administration of 3 capsules with 500mg of curcumin and piperine per day, for 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Supplement B</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Administration of 3 capsules with 500mg of placebo (maize starch) per day, for 12 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Active Comparator: Supplement A</intervention_name>
    <description>The patients will receive 3 capsules per day containing 500mg of curcumin and 5mg of piperine for 4 weeks</description>
    <arm_group_label>Supplement A</arm_group_label>
    <other_name>Curcumin and piperine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo Comparator: Supplement B</intervention_name>
    <description>The patients will receive 3 capsules of placebo per day containing 500mg of maize starch for 4 weeks</description>
    <arm_group_label>Supplement B</arm_group_label>
    <other_name>Placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of Chronic Kidney Disease

          -  Hemodialysis patients for more than 6 months

          -  Aged 18 years or older

          -  Must be able to swallow tablets

        Exclusion Criteria:

          -  Patients pregnant

          -  Smokers

          -  Using antibiotics in the last 3 months

          -  Using antioxidant supplements in the last 3 months

          -  Usual intake of turmeric

          -  Usual intake Autoimmune

          -  Clinical diagnosis of infectious diseases

          -  Clinical diagnosis of Cancer

          -  Clinical diagnosis of AIDS
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Denise Mafra</name>
      <address>
        <city>Niter√≥i</city>
        <state>Rio De Janeiro</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 21, 2018</study_first_submitted>
  <study_first_submitted_qc>March 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 23, 2018</study_first_posted>
  <last_update_submitted>April 3, 2018</last_update_submitted>
  <last_update_submitted_qc>April 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Universidade Federal Fluminense</investigator_affiliation>
    <investigator_full_name>Denise Mafra</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Curcumin</mesh_term>
    <mesh_term>Piperine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

